Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuropsychological assessments in a large cohort of pediatric palliative epilepsy surgery patients.

Epilepsy & behavior : E&B·2026
Same author

Preconditions Contributing to Interprofessional Collaboration in the Management of COPD in Primary Care: A Scoping Review.

International journal of integrated care·2025
Same author

The UTRs of Leishmania donovani vary in length and are enriched in potential regulatory structures.

bioRxiv : the preprint server for biology·2025
Same author

Perceived barriers and solutions by generalist physicians to work towards timely young-onset dementia diagnosis.

Aging & mental health·2023
Same author

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

First Direct Detection Constraints on Planck-Scale Mass Dark Matter with Multiple-Scatter Signatures Using the DEAP-3600 Detector.

Physical review letters·2022

Related Experiment Video

Updated: Jul 25, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

Medication errors in neonatal and paediatric intensive-care units.

T N Raju1, S Kecskes, J P Thornton

  • 1Division of Neonatology, University of Illinois Hospital, College of Medicine, Chicago.

Lancet (London, England)
|August 12, 1989
PubMed
Summary

Medication errors in neonatal and pediatric intensive care units occurred at a rate of 14.7%, leading to patient injury in 3.1% of admissions. Continuous monitoring can help prevent these iatrogenic complications.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Related Experiment Videos

Last Updated: Jul 25, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Area of Science:

  • Pediatric Critical Care Medicine
  • Medication Safety
  • Quality Assurance in Healthcare

Background:

  • Iatrogenic medication errors pose a significant risk in neonatal and pediatric intensive care units (NICUs/PICUs).
  • Understanding the frequency and impact of these errors is crucial for patient safety.

Purpose of the Study:

  • To quantify the incidence and severity of iatrogenic medication errors in NICUs/PICUs.
  • To assess the rate of patient injury resulting from these medication errors.
  • To evaluate the utility of a longitudinal monitoring system for identifying and preventing such errors.

Main Methods:

  • A 4-year prospective quality assurance study was conducted.
  • Data were collected on 2147 neonatal and pediatric intensive care admissions.
  • All reported iatrogenic medication errors and associated patient injuries were documented.

Main Results:

  • A total of 315 iatrogenic medication errors were reported, an error rate of 14.7% (1 per 6.8 admissions).
  • Iatrogenic injury occurred in 3.1% of admissions (66/2147), with 1 injury per 33 admissions.
  • Potentially serious errors accounted for 10.5% (33/315), and mild injuries for 10.2% (32/315). One case involved acute aminophylline poisoning due to a tenfold overdose.

Conclusions:

  • Iatrogenic medication errors are common in NICUs/PICUs and can lead to significant patient harm.
  • A longitudinal monitoring system is valuable for identifying iatrogenic complications and informing preventive strategies.
  • Implementing robust quality assurance measures is essential to improve medication safety in pediatric critical care.